Cargando…
Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms
Kaposi’s sarcoma herpesvirus (KSHV) is associated with a significant disease burden, in particular in Sub-Sahara Africa. A KSHV vaccine would be highly desirable, but the mechanisms underlying neutralizing antibody responses against KSHV remain largely unexplored. The complex made of glycoproteins H...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953146/ https://www.ncbi.nlm.nih.gov/pubmed/35336948 http://dx.doi.org/10.3390/v14030541 |
_version_ | 1784675778554757120 |
---|---|
author | Fricke, Thomas Großkopf, Anna K. Ensser, Armin Backovic, Marija Hahn, Alexander S. |
author_facet | Fricke, Thomas Großkopf, Anna K. Ensser, Armin Backovic, Marija Hahn, Alexander S. |
author_sort | Fricke, Thomas |
collection | PubMed |
description | Kaposi’s sarcoma herpesvirus (KSHV) is associated with a significant disease burden, in particular in Sub-Sahara Africa. A KSHV vaccine would be highly desirable, but the mechanisms underlying neutralizing antibody responses against KSHV remain largely unexplored. The complex made of glycoproteins H and L (gH/gL) activates gB for the fusion of viral and cellular membranes in all herpesviruses. KSHV gH/gL also interacts with cellular Eph family receptors. To identify optimal antigens for vaccination and to elucidate neutralization mechanisms, we primed mice with recombinantly expressed, soluble gH/gL (gHecto/gL) that was either wildtype (WT), lacking defined glycosylation sites or bearing modified glycosylation, followed by boosts with WT gHecto/gL. We also immunized with a gL-gHecto fusion protein or a gHecto-ferritin/gL nanoparticle. Immune sera neutralized KSHV and inhibited EphA2 receptor binding. None of the regimens was superior to immunization with WT gHecto/gL with regard to neutralizing activity and EphA2 blocking activity, the gL-gHecto fusion protein was equally effective, and the ferritin construct was inferior. gH/gL-targeting sera inhibited gB-mediated membrane fusion and inhibited infection also independently from receptor binding and gL, as demonstrated by neutralization of a novel KSHV mutant that does not or only marginally incorporate gL into the gH/gL complex and infects through an Eph-independent route. |
format | Online Article Text |
id | pubmed-8953146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89531462022-03-26 Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms Fricke, Thomas Großkopf, Anna K. Ensser, Armin Backovic, Marija Hahn, Alexander S. Viruses Article Kaposi’s sarcoma herpesvirus (KSHV) is associated with a significant disease burden, in particular in Sub-Sahara Africa. A KSHV vaccine would be highly desirable, but the mechanisms underlying neutralizing antibody responses against KSHV remain largely unexplored. The complex made of glycoproteins H and L (gH/gL) activates gB for the fusion of viral and cellular membranes in all herpesviruses. KSHV gH/gL also interacts with cellular Eph family receptors. To identify optimal antigens for vaccination and to elucidate neutralization mechanisms, we primed mice with recombinantly expressed, soluble gH/gL (gHecto/gL) that was either wildtype (WT), lacking defined glycosylation sites or bearing modified glycosylation, followed by boosts with WT gHecto/gL. We also immunized with a gL-gHecto fusion protein or a gHecto-ferritin/gL nanoparticle. Immune sera neutralized KSHV and inhibited EphA2 receptor binding. None of the regimens was superior to immunization with WT gHecto/gL with regard to neutralizing activity and EphA2 blocking activity, the gL-gHecto fusion protein was equally effective, and the ferritin construct was inferior. gH/gL-targeting sera inhibited gB-mediated membrane fusion and inhibited infection also independently from receptor binding and gL, as demonstrated by neutralization of a novel KSHV mutant that does not or only marginally incorporate gL into the gH/gL complex and infects through an Eph-independent route. MDPI 2022-03-05 /pmc/articles/PMC8953146/ /pubmed/35336948 http://dx.doi.org/10.3390/v14030541 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fricke, Thomas Großkopf, Anna K. Ensser, Armin Backovic, Marija Hahn, Alexander S. Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms |
title | Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms |
title_full | Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms |
title_fullStr | Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms |
title_full_unstemmed | Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms |
title_short | Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms |
title_sort | antibodies targeting kshv gh/gl reveal distinct neutralization mechanisms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953146/ https://www.ncbi.nlm.nih.gov/pubmed/35336948 http://dx.doi.org/10.3390/v14030541 |
work_keys_str_mv | AT frickethomas antibodiestargetingkshvghglrevealdistinctneutralizationmechanisms AT großkopfannak antibodiestargetingkshvghglrevealdistinctneutralizationmechanisms AT ensserarmin antibodiestargetingkshvghglrevealdistinctneutralizationmechanisms AT backovicmarija antibodiestargetingkshvghglrevealdistinctneutralizationmechanisms AT hahnalexanders antibodiestargetingkshvghglrevealdistinctneutralizationmechanisms |